Indefinite Delivery Contract 75D30122D12932

Award Date 12/1/21
Last Date to Order 11/30/26
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a multiple award, indefinite delivery contract to Sanofi Pasteur Inc. to provide up to $1.683 billion in pediatric vaccines for the CDC's Vaccines for Children program. This 12-month contract enables the CDC and its Immunization Awardees to order a range of 20 standard pediatric vaccines including DTaP, IPV, Hepatitis A/B, Hib, HPV, MMR, MCV4, PCV13, Rotavirus, Td, Tdap, and Varicella vaccines....
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...
The Centers for Disease Control and Prevention awarded a single award indefinite delivery contract to Pfizer Inc. for vaccine storage and rotation services. The contract has a potential value of $3 million with a firm fixed price delivery order issued for $2.3 million. Pfizer will provide storage and rotation of vaccines from August 1, 2022 through July 31, 2027 in New York, New York. The contract aims to procure vaccine storage and rotation services from Pfizer to support the CDC's vaccine...
The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023. Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado...
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts to Sanofi Pasteur Inc. for the procurement of adult vaccines. The contracts have a potential value of $39.08 million to supply 13 standard adult vaccines over a one year period from July 1, 2021 through June 30, 2022. Vaccines will be delivered within 15 business days of order to support immunization programs in 50 state health departments and large cities, as provided under Section 317(j) of the Public...
This Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. is for the procurement of pediatric COVID-19 vaccines. The $23,763,000 multiple-award contract has an ultimate completion date of May 31, 2026. As a leading global vaccine manufacturer, Sanofi Pasteur provides a wide range of immunization products to various federal agencies, including seasonal and pandemic influenza vaccines, pediatric vaccines, adult vaccines, and...
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD), awarded a multiple-award Indefinite Delivery Contract to Sanofi Pasteur Inc. to purchase 12 standard adult vaccines. The $42.2 million contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and does not have any set-aside designation. The solicitation required offerors to provide minimum and maximum order quantities ranging from 100 to 1,000,000 doses...
This federal contract IDV award from the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. is for the supply of 2025-2026 pediatric flu vaccines. The $70.18M multiple award contract has a period of performance through February 2026. As the prime contractor, Sanofi Pasteur will leverage its pharmaceutical manufacturing and distribution capabilities to fulfill task orders for pediatric influenza vaccines in support of the CDC's public health mission. The contract was...
The Centers for Disease Control and Prevention (CDC) has awarded a 5-year, multiple-award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the purchase of various adult vaccines. The contract has a ceiling value of $54,975,837.60 and covers the period from July 1, 2024 to June 30, 2025, with the possibility of subsequent option years. As the prime contractor, Sanofi Pasteur Inc. will provide a range of vaccines including Hepatitis A, Hepatitis B, Hepatitis A&B combination,...
Sanofi Pasteur Inc. was awarded a single-award indefinite delivery contract by the Department of Health and Human Services Centers for Disease Control and Prevention potentially valued at $64 million. The contract provides for the delivery of seasonal influenza vaccines to support public health programs as outlined in Section 317(j) of the Public Health Service Act. Performance will occur at the prime contractor's manufacturing facility in Swiftwater, Pennsylvania or other locations as needed to...
  • 75D30122D12932
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

The Centers for Disease Control and Prevention awarded a single-award, indefinite delivery contract to Sanofi Pasteur Inc. with a potential value of $13 million to provide vaccine storage and rotation services from December 2021 through November 2026. Under the initial firm fixed price delivery order valued at $1.8 million, Sanofi Pasteur will store and manage approximately 6.7 million doses of various pediatric vaccines at its Swiftwater, Pennsylvania facility in support of CDC programs.

The original July 2021 solicitation sought these services to maintain a national stockpile of Sanofi-manufactured pediatric vaccines for potential disease outbreaks or supply shortages. As the sole manufacturer, only Sanofi could regularly rotate expiring doses with new product to preserve at least a 12-month shelf life across the stockpile, as required for emergency deployment readiness. The contract aims to ensure a viable vaccine supply is continuously available to the CDC through Sanofi's management of the stockpile.

Generated 1/5/24, 1:43 AM